Cite
HARVARD Citation
Dagogo‐Jack, S. et al. (2018). Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo‐controlled randomized study. Diabetes, obesity & metabolism. 20 (3), pp. 530-540. [Online].